Get startedLog in
    Picture of Theratechnologies logo

    TH — Theratechnologies News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapTurnaround
    All News

    Brief: Theratechnologies Announces Dosing Of First Patient In Updated Clinical Trial Of Sudocetaxel Zendusortide In Advanced Ovarian Cancer

    Picture of Theratechnologies logoTheratechnologies
    12/10/2023 12:35
    Oct 12 (Reuters) - Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES ANNOUNCES DOSING OF FIRST PATIENT IN
UPDATED
CLINICAL TRIAL OF SUDOCETAXEL ZENDUSORTIDE IN ADVANCED OVARIAN
CANCER

Source text for Eikon:  ID:nGNX6T9D1m 
Further company coverage:  TH.TO 

 ((Reuters.Briefs@thomsonreuters.com))

    Recent news on Theratechnologies

    See all news